AstraZeneca antibody drug effective at treating mild Covid-19 in trial

The cocktail halved the risk of developing severe illness or death compared with a placebo in participants who had been symptomatic for a week or less and weren't hospitalized, Astra said.

from Latest News https://ift.tt/3aoqOoe
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share